These data indicate that TP73‐AS1 and CRNDE might be valuable biomarkers for diagnosing NSCLC and that the two lncRNAs in combination with CEA or CEA/CYFRA21‐1 should be an ideal diagnostic panel for NSCLC. The gene discussed is TP73; the disease is non-small cell lung carcinoma.